Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > I'm actually having more fun watching SONA go down

<< Previous

Bullboard Posts

Next >>

Comment by GarlicToaston Apr 14, 2020 3:51pm

113 Views

Post# 30908816

RE:I'm actually having more fun watching SONA go down

Let’s leave SONA alone and deal with AGN. SONA will do ok and had a nice run up and seems to have a very good products in the works. Late but not out.

-GT

luvhorses - (4/14/2020 3:41:35 PM)
I'm actually having more fun watching SONA go down

If I was a SONA shareholder, I would funken peeved right now as it looks like they don't have the goods...all talk??

AGN has the goods...remember, it's all about the SCIENCE!! You can't argue about the chemicals particularly when they prove to a successful mixture!

Down day today but we're in for something special later this week!

<< Previous

Bullboard Posts

Next >>

Multi-bagger penny stock announces high-grade expansion